Hostname: page-component-84b7d79bbc-7nlkj Total loading time: 0 Render date: 2024-07-27T18:15:48.071Z Has data issue: false hasContentIssue false
  • English
  • Français

Substance Use Disorders and ADHD

Published online by Cambridge University Press:  07 November 2014

Oscar Bukstein
Get access Rights & Permissions [Opens in a new window]

Extract

In examining the challenges in treating comorbid attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD), there are a number of issues regarding misinformation and misconception that exist for clinicians. Like other ADHD comorbidities, there is a lack of screening, particularly among adult clinical populations who have the psychiatric comorbidity or, for patients with SUDs, there is the issue of prioritization, which condition to treat first, and determining the place of medication management—particularly stimulant medication—paramount in treatment planning.

Type
Expert Panel Supplement
Information
CNS Spectrums , Volume 14 , Issue S6: Differential Diagnosis of Adult Attention deficit/Hyperactivity Disorder: Treatment Options and Comorbidity Considerations , July 2009 , pp. 10 - 12
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Chan, YF, Dennis, ML, Funk, RR. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat. 2008;34(1):14–24.CrossRefGoogle ScholarPubMed
2.Fayyad, J, De Graaf, R, Kessler, R, et al.Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402–409.CrossRefGoogle ScholarPubMed
3.Wilens, TE. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry. 2007;68(suppl 11):4–8.Google ScholarPubMed
4.Fergusson, DM, Norwood, LJ, Ridder, EM. Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: results of a 25-year longitudinal study. Drug Alcohol Depend. 2007,88(suppl 1):S14–S26.CrossRefGoogle ScholarPubMed
5.Elkins, IJ, McGue, M, Iacono, WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry. 2007;64(10):1145–1152.CrossRefGoogle ScholarPubMed
6.Volkow, ND, Fowler, JS, Logan, J, et al.Effects of modafinil on dopamme and dopamine transporters in the male human brain: clinical implications. JAMA. 2009;301(11):1148–1154.CrossRefGoogle ScholarPubMed
7.Mariani, JJ, Levin, FR. Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict. 2007;16(suppl 1):45–54.CrossRefGoogle ScholarPubMed